Readers' responses to "the cost of marginal medici...[MedGenMed. 2006] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: MedGenMed. 2006 May 15;8(2):44; author reply 43. Links

Comment on:: MedGenMed. 2005;7(4):67.

Readers' responses to "the cost of marginal medicine is too high".

PMID: 16926782 [PubMed - indexed for MEDLINE]

Related articles

Macular degeneration, patients' groups, and pharma.
Lancet. 2007 Jul 21; 370(9583):194.

[Lancet. 2007]
A value-based medicine comparison of interventions for subfoveal neovascular macular degeneration.
Ophthalmology. 2007 Jun; 114(6):1170-8. Epub 2007 Feb 23.

[Ophthalmology. 2007]
[Treatment of neovascular age-related macular degeneration: an unresolved matter]
Arch Soc Esp Oftalmol. 2008 Jul; 83(7):405-6.

[Arch Soc Esp Oftalmol. 2008]
ReviewExpanding treatment options in age-related macular degeneration.
Int Ophthalmol Clin. 2006 Fall; 46(4):123-9.

[Int Ophthalmol Clin. 2006]
ReviewRanibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation.
Health Technol Assess. 2008 May; 12(16):iii-iv, ix-201.

[Health Technol Assess. 2008]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

Readers' responses to "the cost of marginal medicine is too high".Readers' responses to "the cost of marginal medicine is too high".

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show